Screener
Idexx Laboratories IDXX Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 62.4%+0.9pp | 62.1%+0.8pp | 61.8%+0.8pp | 61.7%+1.0pp | 61.5%+1.1pp | |
| Operating margin | 32%+0.9pp | 31.6%+2.5pp | 31.6%+2.7pp | 31.3%+2.4pp | 31.1%+2.5pp | |
| Net margin | 25%+0.6pp | 24.6%+1.9pp | 24.6%+1.8pp | 24.7%+2.1pp | 24.4%+2.1pp | |
| Returns | ||||||
| Return on equity | 74.2%+9.3pp | 72.9%+13.6pp | 66.2%+8.5pp | 64.6%+5.2pp | 64.9%+1.6pp | |
| Return on invested capital | 61.1%+10.1pp | 56.9%+11.4pp | 53.8%+7.4pp | 51.8%+6.8pp | 51%+6.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.3×+0.1× | 1.3×+0.2× | 1.3×+0.1× | 1.2×0.0× | 1.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.2×+0.1× | 1.1×0.0× | 1.2×-0.1× | 1.2×-0.2× | 1.1×-0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×-0.2× | 0.4×-0.1× | 0.4×-0.1× | 0.4×0.0× | 0.5×-0.1× | |
| Per Share | ||||||
| Book value per share | $20.33+12.9% | $19.41+9.8% | $19.81+3.4% | $19.35-0.7% | $18.01-4.9% | |
| Valuation | ||||||
| Market capitalization | $40.43B-19.6% | $44.63B+31.1% | $54.02B+59.6% | $51.11B+22.4% | $42.66B+5.4% | |
| Price / earnings | 35.5×-13.5× | 40.7×+2.7× | 51×+12.9× | 49.7×+1.6× | 43.3×-4.6× | |
| Price / sales | 8.9×-3.2× | 10×+1.4× | 12.6×+3.9× | 12.3×+1.4× | 10.6×-0.1× | |
| Price / book | 25.1×-7.2× | 28.7×+5.2× | 33.7×+12.4× | 32.7×+6.9× | 29.2×+3.6× |
FAQ
- What are Idexx Laboratories's profit margins?
- Idexx Laboratories (IDXX) runs a 62.4% gross margin and a 32.0% operating margin, with a 25.0% net margin.
- Where do Idexx Laboratories's ratios come from?
- Every ratio is computed from Idexx Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
